CLINICAL_TRIALS trial_result · 2026-04-22

Clinical Trial Update: A Study of Psilocybin for Major Depressive Disorder (MDD) [Phase 2]

Phase 2 trial of psilocybin for major depressive disorder has completed and results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Sponsor: Usona Institute | Conditions: Depressive Disorder, Major | Phase 2 | Status: COMPLETED | Results posted: 2026-04-22